Effects of oral non-peptidic thrombopoietin receptor agonists on hepatic enzyme in adult patients with immune thrombocytopenia: a meta-analysis
|更新时间:2026-02-27
|
Effects of oral non-peptidic thrombopoietin receptor agonists on hepatic enzyme in adult patients with immune thrombocytopenia: a meta-analysis
“The latest research focuses on the treatment of adult immune thrombocytopenia. Through meta-analysis of 12 randomized controlled trials and 1388 patient data, experts have verified that oral non peptide TPO RAs do not significantly increase the risk of elevated liver enzymes in patients, and have good liver safety, providing strong evidence for clinical medication safety.”
LU Tiantian,SHEN Nan,ZHU Suyue,et al.Effects of oral non-peptidic thrombopoietin receptor agonists on hepatic enzyme in adult patients with immune thrombocytopenia: a meta-analysis[J].ZHONGGUO YAOFANG,2026,37(04):510-515.
LU Tiantian,SHEN Nan,ZHU Suyue,et al.Effects of oral non-peptidic thrombopoietin receptor agonists on hepatic enzyme in adult patients with immune thrombocytopenia: a meta-analysis[J].ZHONGGUO YAOFANG,2026,37(04):510-515. DOI: 10.6039/j.issn.1001-0408.2026.04.17.
Effects of oral non-peptidic thrombopoietin receptor agonists on hepatic enzyme in adult patients with immune thrombocytopenia: a meta-analysis